| AMINO ACID SYNTHETIC FORMULA SUPPLEMENTED WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS,
MEDIUM CHAIN TRIGLYCERIDES AND 2- FUCOSYLLACTOSE AND LACTO-N-NEOTETRAOSE |
Alfamino® |
NESTLE AUSTRALIA LTD |
Cows' milk protein enteropathy; Severe cows' milk protein enteropathy with failure to thrive; Combined intolerance to cows' milk protein, soy protein and protein hydrolysate formulae; Cows' milk anaphylaxis; Proven combined immunoglobulin E (IgE) mediated allergy to cows' milk protein and
soy protein; Severe intestinal malabsorption including short bowel syndrome; Eosinophilic oesophagitis. |
Nov 2022 |
Recommended |
| ADALIMUMAB; UPADACITINIB |
|
ABBVIE PTY LTD |
All adalimumab indications except juvenile idiopathic arthritis. Severe active rheumatoid arthritis. |
Nov 2022 |
Not Recommended |
| DUPILUMAB |
Dupixent® |
SANOFI-AVENTIS AUSTRALIA PTY LTD |
Chronic severe atopic dermatitis; Uncontrolled severe asthma. |
Nov 2022 |
Recommended |
| ETANERCEPT |
Nepexto® |
ALPHAPHARM PTY LTD |
Rheumatoid arthritis; Juvenile idiopathic arthritis; Psoriatic arthritis; Plaque psoriasis; Ankylosing spondylitis. |
Nov 2022 |
Recommended |
| DAROLUTAMIDE |
Nubeqa® |
BAYER AUSTRALIA LTD |
Prostate cancer |
Nov 2022 |
Deferred |
| POLATUZUMAB VEDOTIN |
Polivy® |
ROCHE PRODUCTS PTY LTD |
Diffuse large B-Cell lymphoma |
Nov 2022 |
Not Recommended |
| PEMBROLIZUMAB |
Keytruda® |
MERCK SHARP & DOHME (AUSTRALIA) PTY LTD |
Cervical cancer |
Nov 2022 |
Recommended |
| SELUMETINIB |
Koselugo® |
ALEXION PHARMACEUTICALS AUSTRALASIA PTY LTD |
Neurofibromatosis type 1 (NF1) |
Nov 2022 |
Not Recommended |
| LANREOTIDE |
Mytolac® |
AMDIPHARM MERCURY (AUSTRALIA) PTY LIMITED |
Acromegaly; Functional carcinoid tumour; Non-functional gastroenteropancreatic neuroendocrine tumour (GEP-NET). |
Nov 2022 |
Recommended |
| MEPOLIZUMAB |
Nucala® |
GLAXOSMITHKLINE AUSTRALIA PTY LTD |
Chronic rhinosinusitis with nasal polyps |
Nov 2022 |
Recommended |
| ONASEMNOGENE ABEPARVOVEC |
Zolgensma® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Spinal muscular atrophy |
Nov 2022 |
Not Recommended |
| PEMBROLIZUMAB |
Keytruda® |
MERCK SHARP & DOHME (AUSTRALIA) PTY LTD |
Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer |
Nov 2022 |
Not Recommended |
| RISEDRONIC ACID |
Actonel® EC |
THERAMEX AUSTRALIA PTY LTD |
Osteoporosis |
Nov 2022 |
Deferred |
| OZANIMOD |
Zeposia® |
CELGENE PTY LIMITED |
Ulcerative colitis |
Nov 2022 |
Recommended |
| IBRUTINIB |
Imbruvica® |
JANSSEN-CILAG PTY LTD |
Chronic lymphocytic leukaemia or small lymphocytic lymphoma |
Nov 2022 |
Not Applicable |
| LENACAPAVIR |
Sunlenca® |
GILEAD SCIENCES PTY LIMITED |
Human immunodeficiency virus infection |
Nov 2022 |
Not Recommended |
| MOBOCERTINIB |
Exkivity® |
TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD. |
Non-small cell lung cancer |
Nov 2022 |
Not Recommended |
| SOTORASIB |
Lumakras® |
AMGEN AUSTRALIA PTY LIMITED |
Non-small cell lung cancer |
Nov 2022 |
Not Applicable |
| MAVACAMTEN |
Camzyos® |
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Hypertrophic cardiomyopathy |
Nov 2022 |
Not Recommended |
| NIVOLUMAB PLUS IPILIMUMAB |
Opdivo® Yervoy® |
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Melanoma |
Nov 2022 |
Recommended |
| INFLIXIMAB |
Remsima® SC |
CELLTRION HEALTHCARE AUSTRALIA PTY LTD |
Rheumatoid arthritis |
Nov 2022 |
Recommended |
| PATIROMER |
Veltassa® |
VIFOR PHARMA PTY LIMITED |
Hyperkalaemia |
Nov 2022 |
Not Recommended |
| UPADACITINIB |
Rinvoq® |
ABBVIE PTY LTD |
Non-radiographic axial spondyloarthritis |
Nov 2022 |
Deferred |
| SELINEXOR |
Xpovio® |
ANTENGENE (AUS) PTY. LTD. |
Multiple myeloma |
Nov 2022 |
Recommended |
| ACALABRUTINIB |
Calquence® |
ASTRAZENECA PTY LTD |
Chronic lymphocytic leukaemia or small lymphocytic lymphoma |
Nov 2022 |
Not Applicable |
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE |
PKU Squeezie® |
VITAFLO AUSTRALIA PTY LIMITED |
Phenylketonuria |
Nov 2022 |
Recommended |
| DOSTARLIMAB |
Jemperli® |
GLAXOSMITHKLINE AUSTRALIA PTY LTD |
Endometrial cancer |
Nov 2022 |
Not Recommended |
| BUDESONIDE WITH GLYCOPYRRONIUM AND FORMOTEROL |
Breztri Aerosphere® DFP-EvoCap |
ASTRAZENECA PTY LTD |
Chronic obstructive pulmonary disease |
Nov 2022 |
Recommended |
| GLYCOMACROPEPTIDE FORMULA WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS AND DOCOSAHEXAENOIC
ACID AND LOW IN PHENYLALANINE |
PKU Sphere Liquid |
VITAFLO AUSTRALIA PTY LIMITED |
Phenylketonuria |
Nov 2022 |
Recommended |
| EMPAGLIFLOZIN |
Jardiance® |
BOEHRINGER INGELHEIM PTY LTD |
Chronic heart failure |
Nov 2022 |
Not Recommended |
| ABIRATERONE AND METHYLPREDNISOLONE |
Yonsa® MPRED |
Sun Pharma ANZ Pty Ltd |
Prostate cancer |
Nov 2022 |
Recommended |
| DEUCRAVACITINIB |
Sotyktu® |
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Plaque psoriasis |
Nov 2022 |
Deferred |
| ELEXACAFTOR WITH TEZACAFTOR AND WITH IVACAFTOR, AND IVACAFTOR |
Trikafta® |
VERTEX PHARMACEUTICALS (AUSTRALIA) PTY. LTD. |
Cystic fibrosis |
Nov 2022 |
Recommended |
| FREMANEZUMAB |
Ajovy® |
TEVA PHARMA AUSTRALIA PTY LTD |
Migraine |
Nov 2022 |
Recommended |
| AVATROMBOPAG |
Doptelet® |
SWEDISH ORPHAN BIOVITRUM PTY LTD |
Chronic immune (idiopathic) thrombocytopenia purpura |
Nov 2022 |
Recommended |
| ALIROCUMAB |
Praluent® |
SANOFI-AVENTIS AUSTRALIA PTY LTD |
Hypercholesterolaemia |
Nov 2022 |
Not Applicable |
| OLAPARIB |
Lynparza® |
ASTRAZENECA PTY LTD |
Ovarian cancer |
Nov 2022 |
Deferred |
| ENFORTUMAB VEDOTIN |
Padcev® |
ASTELLAS PHARMA AUSTRALIA PTY LTD |
Urothelial cancer |
Nov 2022 |
Deferred |
| RANIBIZUMAB |
Susvimo® |
ROCHE PRODUCTS PTY LTD |
Neovascular (wet) age-related macular degeneration |
Nov 2022 |
Not Applicable |
| MIDAZOLAM |
Zyamis® |
CLINECT PTY LTD |
Epilepsy |
Nov 2022 |
Recommended |
| ASCIMINIB |
Scemblix® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Chronic myeloid leukaemia |
Nov 2022 |
Recommended |
| NIVOLUMAB |
Opdivo® |
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD |
Oesophageal carcinoma or gastroesophageal junction carcinoma |
Nov 2022 |
Recommended |
| RISANKIZUMAB |
Skyrizi® |
ABBVIE PTY LTD |
Crohn Disease |
Nov 2022 |
Recommended |
| RUXOLITINIB |
Jakavi® |
NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED |
Chronic Graft vs Host Disease |
Nov 2022 |
Recommended |
| UPADACITINIB |
Rinvoq® |
ABBVIE PTY LTD |
Ulcerative colitis |
Nov 2022 |
Recommended |
| VOSORITIDE |
Voxzogo® |
BIOMARIN PHARMACEUTICAL AUSTRALIA PTY LTD |
Achondroplasia |
Nov 2022 |
Recommended |